NCT05292885

Mp-MRI in the Diagnosis of Liver Fibrosis After Liver Transplantation

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 40 (estimated)
• Sponsor: The Affiliated Hospital of Qingdao University · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: —

Summary

It is an open label observation clinical trial, all participants are liver transplant patients. The investigators deem to make a better criteria for assessing liver fibrosis after liver transplantation. The point of the clinical trial is to evaluate the efficacy of multiparameter MRI in the diagnosis of liver fibrosis after liver transplantation.

Detailed description

We collected patients aged 18 to 85 who had undergone liver transplantation. At the same time, all patients underwent liver biopsy or ultrasonic transient elastography after MRI. People who were allergic to gadolinium contrast agent, serious cardiopulmonary disease and contraindications to MRI were excluded.

Conditions

• Liver Fibrosis After Liver Transplantation
• Multiparameter Magnetic Resonance Imaging

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Gadopentetate Dimeglumine Injection	Patients with liver fibrosis after liver transplantation receive multi-parameter magnetic resonance scanning, percutaneous liver biopsy (or FibroScan).

Timeline

• Start date: 2022-03-18
• Primary completion: 2022-12-01
• Completion: 2022-12-01
• First posted: 2022-03-23
• Last updated: 2022-03-23

Locations

1 site across 1 country: China